Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Metformin and HRS-7535 in Healthy Subjects
NCT06727838Phase 1Completed
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Start
- Dec 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of HRS-7535 in diabetes mellitus (DM), sponsored by Shandong Suncadia Medicine Co., Ltd. Primary endpoints: Maximum plasma concentration, Area under the plasma concentration-time curve from time zero to the time of last quantifiable analyte concentration and 1 more. Started Dec 2024; status: completed.
02
Drugs
HRS-7535
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT06727838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06727838.